IFX monitoring
RIDA®QUICK IFX Monitoring
- Quality, speed, convenience – all in one package!
- Fast and convenient implementation
- All R-biopharm rapid tests pass QMCD quality control
R-biopharm's rapid test is designed for the quantitative determination of infliximab (IFX, Remicade®) and the biosimilars Remsima® and Inflectra® in human serum and plasma.
Allows quantitative determination of infliximab levels within 20 minutes.
In the package:
25 cartridges
Ask for more information!
Liis Mäekivi, Product Manager
Phone: +372 5103961